Position
Director
Company
TFS HealthScience
Description
TFS HealthScience announces the appointment of Markus Granlund as CEO to lead the company's strategic expansion in the ophthalmology sector. Granlund's leadership aims to enhance the efficiency of clinical trial execution while responding to the growing demand for innovative eye care therapies.
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months